NCT02864810View on ClinicalTrials.gov

Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

August 4, 2016

Primary Completion Date

September 9, 2017

Study Completion Date

September 9, 2017

Conditions

Thromboembolism

Interventions

DRUG

[18F]GP1

\[18F\]GP1 PET/CT imaging for detecting thromboembolism

Trial Locations (1)

05505

Asan Foundation, Seoul

Sponsors

Lead Sponsor

Asan Foundation

All Listed Sponsors

lead

Asan Foundation

OTHER